NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Myovant Sciences Ltd (NYSE: MYOV)
MYOV Technical Analysis
5
As on 9th Mar 2023 MYOV STOCK Price closed @ 26.98 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 14.92 & Strong Buy for SHORT-TERM with Stoploss of 20.81 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MYOVSTOCK Price
Open | 26.99 | Change | Price | % |
High | 27.00 | 1 Day | -0.01 | -0.04 |
Low | 26.98 | 1 Week | 0.02 | 0.07 |
Close | 26.98 | 1 Month | 0.08 | 0.30 |
Volume | 2213984 | 1 Year | 4.89 | 22.14 |
52 Week High 27.02 | 52 Week Low 7.78 |
NYSE USA Most Active Stocks
FSR | 0.02 | 0.00% |
DDR | 15.44 | -4.46% |
BBD | 2.70 | 18.94% |
TWTR | 53.70 | 0.66% |
PLTR | 119.15 | 7.85% |
SWN | 7.11 | -0.56% |
F | 10.28 | 0.00% |
BACA-U | 302.00 | 0.67% |
ENLC | 14.12 | -0.21% |
HIMS | 51.40 | -1.81% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
MYOV Daily Charts |
MYOV Intraday Charts |
Whats New @ Bazaartrend |
MYOV Free Analysis |
|
MYOV Important Levels Intraday
RESISTANCE | 27.02 |
RESISTANCE | 27.01 |
RESISTANCE | 27.00 |
RESISTANCE | 26.99 |
SUPPORT | 26.97 |
SUPPORT | 26.96 |
SUPPORT | 26.95 |
SUPPORT | 26.94 |
MYOV Forecast May 2025
4th UP Forecast | 37.02 |
3rd UP Forecast | 33.8 |
2nd UP Forecast | 31.81 |
1st UP Forecast | 29.82 |
1st DOWN Forecast | 24.14 |
2nd DOWN Forecast | 22.15 |
3rd DOWN Forecast | 20.16 |
4th DOWN Forecast | 16.94 |
MYOV Weekly Forecast
4th UP Forecast | 35.03 |
3rd UP Forecast | 32.45 |
2nd UP Forecast | 30.85 |
1st UP Forecast | 29.26 |
1st DOWN Forecast | 24.70 |
2nd DOWN Forecast | 23.11 |
3rd DOWN Forecast | 21.51 |
4th DOWN Forecast | 18.93 |
MYOV Forecast2025
4th UP Forecast | 64.34 |
3rd UP Forecast | 52.36 |
2nd UP Forecast | 44.95 |
1st UP Forecast | 37.55 |
1st DOWN Forecast | 16.41 |
2nd DOWN Forecast | 9.01 |
3rd DOWN Forecast | 1.6 |
4th DOWN Forecast | -10.38 |
Myovant Sciences Ltd ( NYSE USA Symbol : MYOV )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MYOV Other Details
Segment | EQ | |
Market Capital | 1975353728.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
MYOV Address
![]() |
MYOV Latest News
MYOV Business Profile
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health and endocrine diseases. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, for the treatment of female infertility as part of assisted reproduction and is under phase 2 clinical trial. Myovant Sciences Ltd. has collaboration with Pfizer Inc. to develop and commercialize relugolix in oncology and women's health. The company was formerly known as Roivant Endocrinology Ltd. and changed its name to Myovant Sciences Ltd. in May 2016. The company was incorporated in 2016 and is based in London, the United Kingdom. Myovant Sciences Ltd. operates as a subsidiary of Sumitovant Biopharma Ltd. Address: 11-12 St. James?s Square, London, United Kingdom, SW1Y 4LB
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service